CClinicalTrials.gg
Enrolling by invitationNCT03927638Updated Jan 31, 2025

Differences in Sitting Versus Standing on Metabolic and Cardiovascular Measurements

An observational study in Overweight and Obesity, sponsored by Montclair State University. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-01-31.

Sponsored by Montclair State University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This investigations examined the effect that posture has on metabolic and cardiovascular measurements. Further, it will explore the potential for body weight status or physical activity to influence these relationships. All subjects will complete a seated condition and a standing condition in a counterbalanced manner.

Read the detailed description

The purpose of the present study was to evaluate both metabolic and cardiovascular responses to acute bouts of computer work while sitting and standing. Cardiovascular measurements were made using continuous non-invasive blood pressure monitoring and metabolic measurements were made using indirect calorimetry. Subjects will be grouped and analyzed based upon the weight status of the subject. All subjects will complete a seated condition and a standing condition in a counterbalanced manner. Investigators hypothesize that metabolic and cardiovascular responses will be elevated in the standing condition compared to sitting.

02

Conditions studied

  • Overweight and Obesity

Browse trials for

03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's planned enrollment of 80 is below the median of 150 across 436 observational studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

Montclair State University is the lead sponsor of 13 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Healthy subjects between the ages of 18 and 50 years.

Inclusion criteria

  • healthy adult

Exclusion criteria

Exclusion Criteria:

  • Have a history of cancer, cardiac issues, hypertension, pulmonary disease, stroke, neurological or muscular dystrophy, uncontrolled diabetes, or any life threatening chronic conditions.
  • Are currently being treated for infectious mononucleosis, hepatitis, pneumonia, or other infectious diseases.
  • Are unable or unwilling to stand in one position continuously for 15-20 minutes at a time.
  • Use nicotine products, or non-contraceptive hormonal therapy (birth control is okay).
  • Are pregnant or trying to become pregnant.
  • Are not between 18 and 50 years of age.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Normal Weight

    Group is determined based upon subjects weight status. Subjects will preform computer work in the seated and standing position in a counterbalanced manner while metabolic and cardiovascular measurements are made.

    Behavioral: sit/stand

  • Overweight/Obese

    Group is determined based upon subjects weight status. Subjects will preform computer work in the seated and standing position in a counterbalanced manner while metabolic and cardiovascular measurements are made.

    Behavioral: sit/stand

Interventions

  • Behavioralsit/stand

    Subjects will be asked to both sit and stand during a single trial.

06

What researchers measure

Primary outcomes

  1. Heart Rate

    Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure heart rate based upon beat-by-beat finger pressure.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  2. Systolic Blood Pressure (SBP)

    Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure SBP based upon beat-by-beat finger pressure.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  3. Diastolic Blood Pressure (DBP)

    Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure DBP based upon beat-by-beat finger pressure.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  4. Oxygen Consumption

    Oxygen consumption will be measured using indirect calorimetry.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  5. Carbon Dioxide Production

    Carbon Dioxide will be measured using indirect calorimetry.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  6. Ventilation

    Ventilation will be measured using indirect calorimetry.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  7. Respiratory Exchange Ration (RER)

    RER will be calculated using oxygen and carbon dioxide value measure from indirect calorimetry.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

Secondary outcomes

  1. Height

    Standard stadiometer will be used to measure height in meters.

    Time frame: 1 minute

  2. Weight

    Standard scale will be used to measure weight in kilograms.

    Time frame: 1 minute

  3. Body Mass Index (BMI)

    Height in meters and weight in kilograms will be used to calculate BMI using the formula BMI = kg/m\^2.

    Time frame: 1 minute

  4. Body Composition

    Body composition will be measured using air displacement plethysmography.

    Time frame: Approximately 15 minutes

  5. Total Peripheral Resistance (TPR)

    Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be uses to estimate TPR based upon beat-by-beat finger pressure.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  6. Stroke Volume

    Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to estimate TPR based upon beat-by-beat finger pressure.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  7. Cardiac Output (Q)

    Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to estimate Q based upon beat-by-beat finger pressure.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

  8. Muscle Oxygen Saturation

    Using Near-inferred spectroscopy muscle oxygen consumption will be monitored.

    Time frame: Approximately 15 minutes in each condition (sitting and standing)

07

Study locations

1 site
  • Montclair State University
    Montclair, New Jersey 07043, United States
08

References and documents

Publications

  • Hosick PA, Willett JM, Matthews EL. Cardiovascular strain and metabolic rate are higher following 15 minutes of standing versus seated computer work. Eur J Prev Cardiol. 2020 Dec;27(19):2131-2133. doi: 10.1177/2047487319867402. Epub 2019 Jul 29. No abstract available. PubMed 31357884 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03927638
Lead sponsor
Montclair State University
Responsible party
Peter A. Hosick (Assistant Professor, Montclair State University) — Principal investigator
First posted
Apr 25, 2019
Start date
Nov 11, 2018
Primary completion
May 15, 2028 (estimated)
Completion
May 15, 2028 (estimated)
Last update
Jan 31, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion